COVID-19: In Germany, MPs vote against mandatory vaccination for over 60 years

The camouflet is size for the successor of Angela Merkel, Olaf Scholz, who had pronounced in the fall for compulsory vaccination for all adults, promised for “late February or early March”.

Le Monde and AFP

The promise of the German Chancellor has been bogged down for months. The OLAF SCHOLZ government has failed on Thursday, April 7, to vote by MPs a vaccine obligation against CVIV-19 from 60 years old. The project obtained 296 votes for but was rejected by 378 deputies. Nine members of the Lower House of the German Parliament abstained.

The camouflet is size for the successor of Angela Merkel, who had pronounced in the fall for mandatory vaccination for all adults, promised for “late February or early March”. But the new social democratic chancellor could not entail all three parties of his own government coalition, which brings together Social Democrats, Ecologists and Liberals, nor the conservative opposition.

Rates of Always high impact in Germany

Despite a proposal for a law dummified in part of its substance, with an obligation reserved for more than 60 years, the government could not come together around its majority project in the Bundestag. The subject is thorny in an Germany where the anti-vascinal movement is strongly mobilized. The Liberals of the FDP, in particular, have rejected for months the idea of ​​a vaccine obligation.

The Chancellor, criticized for his discretion and lack of leadership, even attracted the sarcasm, Thursday, forcing his degree of diplomacy, Annalya Baerbock, to leave a NATO meeting in Brussels on the Ukraine to come and participate in the vote, have reported several media.

The health situation remains degraded in Germany, which recorded in recent days more than 200,000 new cases every twenty-four hours. The seven-day incidence rate exceeds 1,200 contaminations at SARC-COV-2 per 100,000 inhabitants. About 76% of the population received two doses of vaccine. Only 58.9% of the Germans received a return dose against the virus, according to the Robert Koch Institute.

/Media reports.